MMP9 and fibrosarcoma: In keratinocytes, down-regulation of CD9 was found to increase activity and expression of MMP9 through JNK signaling [20], while in a fibrosarcoma cell line, epithelial growth factor receptor, EGFR, was an important intermediary for increased release of pro-MMP9 by CD9 [21].